Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKesson
Boehringer Ingelheim
Deloitte
QuintilesIMS
Colorcon
Cantor Fitzgerald
Fuji
Harvard Business School

Generated: May 23, 2018

DrugPatentWatch Database Preview

Alosetron hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for alosetron hydrochloride and what is the scope of alosetron hydrochloride freedom to operate?

Alosetron hydrochloride
is the generic ingredient in two branded drugs marketed by Amneal Pharms, Par Pharm Inc, West-ward Pharms Int, and Sebela Ireland Ltd, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for alosetron hydrochloride. Seven suppliers are listed for this compound.
Pharmacology for alosetron hydrochloride
Synonyms for alosetron hydrochloride
122852-69-1
132414-02-9
1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-
1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-, monohydrochloride
1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2((5-methyl-1H-imidazol-4-yl)methyl)-, monohydrochloride
2,3,4,5-Tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one monohydrochloride
2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyridol(4,3-b)indol-1-one monohydrochloride
2,3,4,5-Tetrahydro-5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-1H-pyrido[4,3-b]indol-1-one Hydrochloride
2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1-H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride
2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride
2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one, monohydrochloride
2F5R1A46YW
5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-3,4-dihydro-2H-pyrido[4,3-b]indol-1(5H)-one hydrochloride
5-METHYL-2-[(5-METHYL-1H-IMIDAZOL-4-YL)METHYL]-1H,2H,3H,4H,5H-PYRIDO[4,3-B]INDOL-1-ONE HYDROCHLORIDE
5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one hydrochloride
5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one hydrochloride
5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one;hydrochloride
852A691
A804978
AB0017713
AC-022
AC1L1TV5
AC1Q3EM0
AK323612
AKOS015889472
AKOS015961658
Alosetron (Hydrochloride(1:X))
Alosetron (Hydrochloride)
Alosetron HCl
Alosetron hydrochloride (USAN)
Alosetron hydrochloride [USAN]
Alosetron hydrochloride, >=98% (HPLC)
Alosetron Hydrochloride(1:X)
alosetron monohydrochloride
AN-16216
API0001419
AT-2898
C17H18N4O.HCl
C17H19ClN4O
CAS-122852-69-1
CC-23908
CCG-100910
CHEBI:53783
CHEMBL1200885
CPD000469211
CS-0642
CTK8F0331
D02829
DSSTox_CID_24208
DSSTox_GSID_44208
DSSTox_RID_80120
DTXSID8044208
EBD27746
FNYQZOVOVDSGJH-UHFFFAOYSA-N
FT-0631109
GR 68755
GR 68755c
GR 68755X
GR-68755
GR-68755C
HSDB 7055
HY-70050C
I01-2212
KS-00000Z0H
Lotrpnex (TN)
LS-172541
LS-172542
MLS001401464
MolPort-006-069-215
MolPort-006-391-882
NC00160
NCGC00167528-01
NCGC00167528-02
PL006356
PubChem21073
Q-200613
Q640
REGID_for_CID_60758
RT-011248
s4694
SAM001246782
SCHEMBL806
SMR000469211
ST51051100
Tox21_112525
Tox21_112525_1
UNII-2F5R1A46YW
VA10239
W-5305

US Patents and Regulatory Information for alosetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 206113-001 Feb 23, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sebela Ireland Ltd LOTRONEX alosetron hydrochloride TABLET;ORAL 021107-001 Feb 9, 2000 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 206647-002 Dec 22, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 200652-001 May 4, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for alosetron hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd LOTRONEX alosetron hydrochloride TABLET;ORAL 021107-002 Dec 23, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Sebela Ireland Ltd LOTRONEX alosetron hydrochloride TABLET;ORAL 021107-001 Feb 9, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Boehringer Ingelheim
UBS
Chinese Patent Office
Argus Health
Covington
Cipla
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.